Profil
Mark L.
Levitt is currently Director at EnGeneIC Pty Ltd. and Chief Scientific Officer at RedHill Biopharma Ltd. since 2017.
Formerly, Dr. Levitt was Director at UPMC Cancer Institute and Head of the Lung Cancer Unit at Sheba Medical Center.
Postes actifs de Mark Levitt
| Sociétés | Poste | Début |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Directeur Technique/Scientifique/R&D | 01/01/2017 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark Levitt
| Sociétés | Poste | Fin |
|---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Directeur/Membre du Conseil | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Health Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
















